This proposal is for continuation of a highly productive Program Project Grant currently in its 9th year. Nine investigators will study the molecular basis of neoplastic disease. Laboratory approaches to the problem of neoplasia are diverse but complementary. The scientific make-up of the group will encourage analysis of basic problems in tumor cell biology from the biochemical level to molecular genetics. Interactions at both the intellectual and technical levels make this cooperative effort much stronger and more economical than nine independent efforts. The growth of cells in normal, adult tissues is tightly regulated. Controls of cell proliferation and of differentiation are both aberrant in cancer cells; indeed the regulatory pathways for both processes may be intimately linked. Virtually all of the studies proposed here center on some aspect of this question of regulatory mechanisms. A priori, these controls may be positive or negative: investigations of both sorts of mechanisms suggested. We will use novel serum-free media to isolate and characterize primary populations of human breast cancer cells to screen by DNA transfer for genes that interfere with tumor forming ability. We will study the types and actions of negative intercellular signals regulating transformation. Potentially major negative controls on cell growth by interferon are investigated. The laboratory will investigate how thymidine kinase mRNA is produced, processed and degraded as an end point determinant of the important G1 phase of the cell cycle. Differentiation is subject to control by exogenous factors. Mutations affecting human epidermal cell differentiation will be investigated. The genetic control of how a preadipocyte cell becomes """"""""locked"""""""" into a determined pathway of differentiation is to be explored. The genetic control differentiation of 3 malignant cellular systems will be studied: teratocarcinoma, pheochromocytoma, and colonic carcinoma. Both the teratocarcinoma and pheochromocytoma system also revert to a less malignant form upon their differentiation, stimulated by retinoic acid and nerve growth factor, respectively. Alterations of the mitochondria of colonic tumor cells will be a particular focus of research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA022427-12
Application #
3092978
Study Section
(SRC)
Project Start
1978-03-01
Project End
1993-02-28
Budget Start
1989-03-01
Budget End
1990-02-28
Support Year
12
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Liang, P; Averboukh, L; Zhu, W et al. (1995) Molecular characterization of the murine thymidylate kinase gene. Cell Growth Differ 6:1333-8
Zou, Z; Anisowicz, A; Hendrix, M J et al. (1994) Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263:526-9
Dou, Q P; Zhao, S; Levin, A H et al. (1994) G1/S-regulated E2F-containing protein complexes bind to the mouse thymidine kinase gene promoter. J Biol Chem 269:1306-13
Dou, Q P; Levin, A H; Zhao, S et al. (1993) Cyclin E and cyclin A as candidates for the restriction point protein. Cancer Res 53:1493-7
Liang, P; Averboukh, L; Pardee, A B (1993) Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res 21:3269-75
Keyomarsi, K; Pardee, A B (1993) Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci U S A 90:1112-6
Fridovich-Keil, J L; Markell, P J; Gudas, J M et al. (1993) DNA sequences required for serum-responsive regulation of expression from the mouse thymidine kinase promoter. Cell Growth Differ 4:679-87
DeFranco, C; Damon, D H; Endoh, M et al. (1993) Nerve growth factor induces transcription of NGFIA through complex regulatory elements that are also sensitive to serum and phorbol 12-myristate 13-acetate. Mol Endocrinol 7:365-79
DeFranco, C; Ro, M; Grossel, M et al. (1993) NGFIA (EGR1) contains transcription activating domains in both the amino terminal and carboxyl terminal regions of the protein. Biochem Biophys Res Commun 194:425-31
Keyomarsi, K; Samet, J; Molnar, G et al. (1993) The thymidylate synthase inhibitor, ICI D1694, overcomes translational detainment of the enzyme. J Biol Chem 268:15142-9

Showing the most recent 10 out of 48 publications